SEI INVESTMENTS CO - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$351,854
+18.1%
64,560
+45.4%
0.00%0.0%
Q2 2023$297,949
-28.0%
44,408
-5.2%
0.00%0.0%
Q1 2023$413,781
+154.6%
46,861
+120.3%
0.00%
Q4 2022$162,503
+18.6%
21,270
+10.8%
0.00%
Q3 2022$137,000
-20.8%
19,192
-10.4%
0.00%
Q2 2022$173,000
-82.1%
21,415
-69.3%
0.00%
-100.0%
Q1 2022$967,000
-50.1%
69,648
+0.9%
0.00%
-50.0%
Q4 2021$1,936,000
-11.8%
69,007
+6.8%
0.00%
-20.0%
Q3 2021$2,196,000
-19.1%
64,611
-2.8%
0.01%
-16.7%
Q2 2021$2,716,000
-28.5%
66,485
-21.5%
0.01%
-40.0%
Q1 2021$3,797,000
-52.3%
84,675
-37.3%
0.01%
-52.4%
Q4 2020$7,964,000
+36.5%
134,947
+12.7%
0.02%
+23.5%
Q3 2020$5,833,000
+6.0%
119,731
+5.2%
0.02%0.0%
Q2 2020$5,505,000
+66.6%
113,790
-4.3%
0.02%
+41.7%
Q1 2020$3,305,000
+96.7%
118,962
+111.9%
0.01%
+140.0%
Q4 2019$1,680,000
+90.7%
56,147
+97.0%
0.01%
+150.0%
Q3 2019$881,000
+19.1%
28,500
+86.1%
0.00%0.0%
Q2 2019$740,00015,3110.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders